Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Nicholson KG
Franchimont N
Smiles: CC(C)NC(=O)COC1=CC(=CC=C1)C1N=C(NC2C=C3C=NNC3=CC=2)C2=CC=CC=C2N=1
30)12-6-4-11(5-7-12)16(26)25(2)3/h4-10
Cells are pretreated with 25-100 μM Salidroside (Sal) for 24 h and then exposed to 500 μM MPP+ for an additional 24 h
Lenalidomide Catalog No.:M8013-2 Nicholson KGLenalidomide, also known as CC 5013, is the thalidomide analog with potential antineoplastic activity. Lenalidomide inhibits TNF alpha production, stimulates T cells, reduces serum levels of the cytokines vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), and inhibits angiogenesis. This agent also promotes G1 cell cycle arrest and apoptosis of malignant cells. Lenalidomide is an approved drug. Product information CAS
US$ 1487.50
US$ 463.48